Blunted serum erythropoietin response to anemia in patients polytransfused for beta-thalassemia major

J Pediatr Hematol Oncol. 1998 Mar-Apr;20(2):140-4. doi: 10.1097/00043426-199803000-00010.

Abstract

Purpose: To investigate the response of erythropoietin (EPO) to anemia in patients polytransfused for beta-thalassemia major.

Patients and methods: We measured the serum EPO levels and the concurrent hemoglobin (Hb) concentrations in 40 patients polytransfused for beta-thalassemia major, in 18 patients with iron deficiency anemia (IDA), and 32 healthy subjects. Serum EPO levels were assayed by an enzyme immunoassay.

Results: In both groups with beta-thalassemia major and IDA, serum EPO levels were significantly elevated (114 +/- 71 and 239 +/- 217 mU/mL, respectively). There was a significant inverse correlation between log EPO values and Hb concentrations in patients with beta-thalassemia major (r = 0.61; p < 0.01) and IDA (r = 0.81; p < 0.01). In a semilogarithmic plot, the slope of the regression line obtained in patients with beta-thalassemia major was significantly lower than that of IDA (p < 0.01), suggesting a blunted EPO response to anemia in patients polytransfused for beta-thalassemia major. The elevation of serum EPO in patients with beta-thalassemia major was poorly related to clinical variables except serum ferritin.

Conclusions: We conclude that a significant inverse relationship between serum EPO levels and Hb concentration exists in patients with beta-thalassemia major. However, this EPO response in patients with anemia caused by beta-thalassemia major may be blunted when compared to patients with IDA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Iron-Deficiency / blood*
  • Blood Transfusion*
  • Child
  • Child, Preschool
  • Erythropoietin / blood*
  • Female
  • Ferritins / blood
  • Hemoglobins / metabolism
  • Humans
  • Immunoenzyme Techniques
  • Infant
  • Male
  • Mutation
  • beta-Thalassemia / blood*
  • beta-Thalassemia / genetics
  • beta-Thalassemia / therapy*

Substances

  • Hemoglobins
  • Erythropoietin
  • Ferritins